Stoke Therapeutics Inc
$ 29.37
1.28%
09 Jun - close price
- Market Cap 1,869,073,000 USD
- Current Price $ 29.37
- High / Low $ 30.06 / 28.57
- Stock P/E N/A
- Book Value 6.34
- EPS -2.86
- Next Earning Report f
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.27 %
- ROE -0.46 %
- 52 Week High 40.22
- 52 Week Low 11.17
About
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops new antisense oligonucleotide (ASO) drugs to treat the underlying causes of serious genetic diseases in the United States. The company is headquartered in Bedford, Massachusetts.
Analyst Target Price
$45.10
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-03-16 | 2025-11-04 | 2025-08-12 | 2025-05-13 | 2025-03-18 | 2024-11-05 | 2024-08-07 | 2024-05-06 | 2024-03-25 | 2023-11-07 | 2023-08-07 |
| Reported EPS | -0.79 | -0.97 | -0.65 | -0.4 | 1.9 | -0.18 | -0.47 | -0.46 | -0.57 | -0.6 | -0.55 | -0.69 |
| Estimated EPS | -0.82 | -0.713 | -0.57 | -0.54 | -0.09 | -0.5302 | -0.54 | -0.56 | -0.61 | -0.63 | -0.64 | -0.66 |
| Surprise | 0.03 | -0.257 | -0.08 | 0.14 | 1.99 | 0.3502 | 0.07 | 0.1 | 0.04 | 0.03 | 0.09 | -0.03 |
| Surprise Percentage | 3.6585% | -36.0449% | -14.0351% | 25.9259% | 2211.1111% | 66.0505% | 12.963% | 17.8571% | 6.5574% | 4.7619% | 14.0625% | -4.5455% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | f |
| Fiscal Date Ending | o |
| Estimated EPS | r |
| Currency | m |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
